Seattle Genetics was founded in 1998 courtesy of Dr. Clay Siegall and other co-founders. The company focuses on meeting the needs of cancer patients through the provision of a diverse pipeline of antibody-based therapies. The company has also been involved in the production of other products to help control other diseases and conditions associated with cancer.
Seattle Genetics is an expanding company which has a diverse portfolio of clinical and also preclinical product candidates. These product candidates aim at controlling different cancer varieties as well as autoimmune indications.
Seattle Genetics has also been ranked among the leading companies in antibody technologies. For instance, the company has been appreciated after it invented its antibody-drug conjugate (ADC) platform.
The company’s success has been enhanced through the contribution of pharmacists and professors such as Dr. Clay Siegall. At the same time, the company has collaborated with other different and successful companies on its way to the top. Some of these companies include Genetech, MedImmune, CuraGen, Progenics, and Bayer. The companies have contributed a total of $5 million to support the company since the year 2001.
As a result, Seattle Genetics has established itself well in Austin, Texas and also in the US at large. Its first product, ADCETRIS, was reviewed and approved in 2011. This is one of the notable accomplishments of the company.
Dr. Siegall participated in co-founding Seattle Genetics in 1998. Currently, he is the President, Executive Officers, and a member of the company’s Board of Directors. His contribution has led to an immense growth of the company.
Dr. Clay Siegall had previously received honors in B.S in Zoology at the University of Maryland. He is also a holder of Ph.D. in Genetics from G. Washington University. Additionally, having worked in many sectors as a director and member in governing bodies, Dr. Siegall has quite a considerable deal of experience that is suitable for Seattle Genetics. For example, he worked with Bristol0Myers Squibb Pharmaceutical Research Institute, National Cancer Institute, and Alder Biopharmaceuticals among other companies.
Seattle Genetics Company has enjoyed success under the vibrant leadership and participative manufacturing of company’s products. Through Dr. Siegall, private companies, and the public, the company has been able to secure funds as donations with which it has used in its development.
Connect with Clay Siegall: